Enzyme adhesive for combating cancer
René Wartner, Andreas Simon and Marcus Böhme have developed a technology that can be used to treat tumours with pinpoint accuracy. Their enzyme adhesive should allow toxins to bind to antibodies and be transported in a targeted way to cancer cells. The three biochemist entrepreneurs plan to market their idea. Read more